Literature DB >> 24398757

Sevoflurane/remifentanil versus propofol/remifentanil for electroconvulsive therapy: comparison of seizure duration and haemodynamic responses.

Hulya Ulusoy1, Bahanur Cekic, Ahmet Besir, Sukran Geze, Cicek Hocaoglu, Ali Akdogan.   

Abstract

OBJECTIVE: To compare the anaesthetic and convulsive effects of sevoflurane/remifentanil versus propofol/remifentanil combination in electroconvulsive therapy (ECT).
METHODS: In this prospective, randomized double-blind study, patients diagnosed with treatment-resistant depression were included for ECT. Prior to treatment, 1 µg/kg remifentanil was intravenously administered to all patients, followed by anaesthetic induction with either 0.5 mg/kg propofol or 8% sevoflurane. Following muscular paralysis with succinylcholine and hypnosis, bitemporal ECT was applied. Vital signs, depth of sedation, recovery parameters, motor and electroencephalography (EEG) convulsion activity and postictal suppression index scores were recorded.
RESULTS: A total of 120 sessions of ECT were administered to 12 patients. Heart rate was higher in the sevoflurane group than the propofol group. Compared with the sevoflurane group, bispectral index level was lower in the propofol group during the induction period and higher during the recovery period. Anaesthetic induction and recovery times were lower, and average motor and EEG convulsion activity was longer, in the propofol group than in the sevoflurane group.
CONCLUSION: Propofol/remifentanil is more successful compared with sevoflurane/remifentanil in anaesthesia management during ECT since it provides quick induction and recovery, longer seizure activity and stable haemodynamics.

Entities:  

Keywords:  Anaesthesia; electroconvulsive therapy; propofol; seizure; sevoflurane

Mesh:

Substances:

Year:  2014        PMID: 24398757     DOI: 10.1177/0300060513509036

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

Review 1.  Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Yoshiteru Takekita; Taro Suwa; Naotaka Sunada; Hirotsugu Kawashima; Chiara Fabbri; Masaki Kato; Aran Tajika; Toshihiko Kinoshita; Toshi A Furukawa; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-01-28       Impact factor: 5.270

2.  Impact of Sevoflurane and Thiopental Used Over the Course of Electroconvulsive Therapy: Propensity Score Matching Analysis.

Authors:  Taisuke Yatomi; Takahito Uchida; Akihiro Takamiya; Masataka Wada; Shun Kudo; Kazuki Nakajima; Hana Nishida; Bun Yamagata; Masaru Mimura; Jinichi Hirano
Journal:  Front Hum Neurosci       Date:  2022-07-08       Impact factor: 3.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.